Related Experiment Video
Updated: Apr 20, 2026
11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
96.2K
Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice
O O Ojo1, D K Srinivasan1, B O Owolabi1
1SAAD Centre for Pharmacy & Diabetes, School of Biomedical Sciences, University of Ulster, Coleraine BT52 1SA, UK.
Biochimica Et Biophysica Acta
|December 3, 2014
Summary
Magainin-AM2 peptide treatment improved glucose tolerance and insulin sensitivity in obese mice. This amphibian peptide shows potential for treating type 2 diabetes by enhancing islet beta cell function.
Area of Science:
- Endocrinology
- Metabolic Research
- Pharmacology
Background:
- Magainin-AM2 is an amphibian host-defense peptide.
- It stimulates insulin and glucagon-like peptide-1 release in vitro.
- Obesity and glucose intolerance are significant health concerns.
Purpose of the Study:
- To investigate the anti-diabetic effects of magainin-AM2.
- To assess its impact on glucose metabolism and insulin sensitivity in diet-induced obese mice.
Main Methods:
- Male NIH Swiss mice were fed a high-fat diet for 12 weeks.
- Daily treatment with magainin-AM2 was administered.
- Glucose tolerance, insulin secretion, and metabolic parameters were monitored.
Main Results:
- Magainin-AM2 treatment significantly decreased blood glucose and increased plasma insulin.
- Oral and intraperitoneal glucose tolerance and insulin secretion were enhanced.
- Insulin sensitivity and islet beta cell responses improved, with reduced fat deposition.
Conclusions:
- Magainin-AM2 effectively improves glucose tolerance, insulin sensitivity, and islet beta cell function in obese diabetic mice.
- This peptide holds promise for the therapeutic treatment of type 2 diabetes.
Related Concept Videos
01:16Hormones Regulating Blood Glucose
9.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
9.1K
01:24Type II Diabetes II: Pathophysiology
2
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
2
01:24Glucagon-like Receptor Agonists
1.4K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.4K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
3.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
3.3K
01:23Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K